Forefront Dermatology (PRIVATE.FOREFRONT)

Overall impact
C (45)

Commentary

Forefront Dermatology is an average overall performer. With a 'C' rating of 45.1 for overall impact (32nd percentile compared to all companies), Forefront Dermatology ranks 63rd out of 71 industry peers, behind ModivCare, Ontrak, Hanger and 59 others, and ahead of Cordental Group Management, GI Alliance, Davita and 5 others. On top material causes for Forefront Dermatology's industry (Healthcare Providers), Forefront Dermatology performs well in Access to Affordable Healthcare (92.7 score), Disease Eradication (87.3) and Child and Maternal Health (95.4) and performs poorly in Racial Justice and Civil Rights (0.0 score), Sustainable Use of Natural Resources (30.9), Improved Mental Health (38.1) and 17 other causes where it received a 'D' or 'F' score.
Impact
Cause PRIVATE.FOREFRONT
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
1977
Employees
1,063
Sector
Health Care
Industry
Health Care Providers & Services
Sub-industry
Health Care Services
SASB industry
Health Care Delivery
Headquarters
Wisconsin, United States
Share classes
PRIVATE.FOREFRONT
Description
Operator of a chain of dermatology practice centers based in Manitowoc, Wisconsin. The company offers general, surgical and cosmetic dermatology care along with related laboratory services using innovative and proven treatments to diagnose and treat skin cancer and all diseases of the skin, hair and nails, thereby offering patients superior access to world-class, board-certified care within their communities.
Material causes
Ethos considers the following causes material for Forefront Dermatology, based on its industry sub-industry Health Care Services. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.